Canada, August 7, 2019 (PROACTIVE)- The firm has had a busy 2019, as it continues its rapid expansion at its facility, while also pushing forward its research and development platform. Completing expansion at its facility, headquartered at the former Kraft plant in Cobourg, Ontario with an aim to build the world’s …Read More »
Tag Archives: FSD Pharma
A pharmacist and drug formulation specialist has been hired to assist with our product applications to Health Canada
TORONTO, July 31, 2019 /CNW/ – Canntab Therapeutics Limited (CSE:PILL.CN) (OTCQX:CTABF) (FRA:TBF1.F) (the “Company” or “Canntab“), the leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, is pleased to provide an update on a number of significant developments, as well as a clear outline of what to expect in …Read More »
Adam Friedman, MD, FAAD, Ken Mackie, MD and Sara Jane Ward, Ph.D. join high-profile FSD Scientific Advisory Team
Canada, July 30, 2019 (STOCKHOUSE)- Expands the Scientific Advisory Board by adding three additional prominent researchers in clinical applications of medicinal cannabis. Adam Friedman, MD, FAAD, Ken Mackie, MD and Sara Jane Ward, Ph.D. join high-profile FSD Scientific Advisory Team FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” …Read More »
FSD Pharma is boosting its scientific advisory board with the appointment of four new medical professionals
Canada, July 30, 2019 (PROACTIVEINVESTORS USA)- The new appointments come as the medical cannabis company advances its efforts to pursue development of CBD-based therapies to replace widely used opioid painkillers in treatment programs. Dr Kaiser was named one of the 50 most influential health executives in 2019 FSD Pharma Inc (CSE:HUGE) …Read More »
FSD Pharma CEO Raza Bokhari said the company plans on uplisting at a major U.S. exchange. He spoke with Green Market Report’s Debra Borchardt at the MJ Link Micro Investor conference in New York on June 25.Read More »
One of the ways to invest in cannabis is through the stock market. If you are looking for cannabis stocks, there are few clear toppers. These include: According to the CEO of Cannabis Stocks, Bruce Linton, cannabis along with other hemp products might be entering the market by the end …Read More »
USA, July 2, 2019, (PROACTIVE INVESTORS USA)- FSD Pharma also has agreed to assume approximately US$3.05 million of outstanding Prismic long- and short-term liabilities. FSD Pharma Inc (CSE: HUGE) (OTCMKTS:FSDDF) announced Tuesday it has closed on the deal to acquire US-based specialty research and development pharma company Prismic Pharmaceuticals Inc. The …Read More »
TORONTO, May 20, 2019, Daniele Piomelli, Ph.D., Ryan Vandrey, Ph.D. and David Casarett, MD, MA Join distinguished group of Scientific Advisors TORONTO, May 20, 2019 /CNW/ – FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”), is pleased to announce that three eminent cannabis researchers have joined the company’s Scientific Advisory …Read More »
Featuring commentary from Dr. Raza Bokhari, executive cochairman of the cannabis company, FSD Pharma. There has been a rapid evolution in the cannabis industry. Formerly a taboo drug, cannabis is increasingly accepted and the subject of regulatory approval. In the United States, it is legal in 33 states to use cannabis …Read More »
Largest Hydroponic Indoor Cannabis Facility in the World FSD Pharma is a licensed producer of medicinal cannabis. We are fully developed. We have three point nine million square feet of facility that would have a capacity to produce 400 thousand kg of cannabis a year over year. We have a …Read More »
Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.
Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.
Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.
Investment Value Finders is intended for those 21+ years of age only!